1015363

Nikhil Khushalani — FEI 3013350093

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 23, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Tampa, FL (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
738821 CFR 50.25(a)(2)Reasonably foreseeable risks or discomforts